{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:48Z","timestamp":1791406008468,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1053\/j.gastro.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T01:34:47Z","timestamp":1469237687000},"page":"973-985.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir"],"prefix":"10.1053","volume":"151","author":[{"given":"Santseharay","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte S.","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Gottwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2016.07.013_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2016.07.013_bib3","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1136\/gutjnl-2012-302048","article-title":"New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets","volume":"61","author":"Ploss","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2016.07.013_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","article-title":"Hepatitis C","volume":"385","author":"Webster","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2016.07.013_bib7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.07.013_bib8","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/hep.26905","article-title":"Is genotype 3 of the hepatitis C virus the new villain?","volume":"59","author":"Goossens","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.gastro.2016.07.013_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2016.07.013_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1053\/j.gastro.2016.07.013_bib12","first-page":"E1101","article-title":"Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2016.07.013_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.gastro.2010.11.036","article-title":"Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha","volume":"140","author":"Scheel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.07.013_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/j.gastro.2011.06.004","article-title":"Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3\/4A protease recombinant viruses","volume":"141","author":"Gottwein","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.07.013_bib15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2013.11.009","article-title":"Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.07.013_bib16","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1073\/pnas.1218260109","article-title":"Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2016.07.013_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm.3610","article-title":"Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation","volume":"20","author":"Yamane","year":"2014","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2016.07.013_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.26660","article-title":"Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors","volume":"59","author":"Ramirez","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JVI.02877-14","article-title":"Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77","volume":"89","author":"Li","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2016.07.013_bib20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/hep.27197","article-title":"Development of hepatitis C virus genotype 3a cell culture system","volume":"60","author":"Kim","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib21","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2016.07.013_bib22","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/AAC.00054-12","article-title":"Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus","volume":"56","author":"Lam","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2016.07.013_bib23","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/JVI.01605-10","article-title":"Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations","volume":"85","author":"Scheel","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2016.07.013_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.27298","article-title":"Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a","volume":"60","author":"Carlsen","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib25","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","article-title":"Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in\u00a0vivo pathogenesis studies","volume":"84","author":"Gottwein","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2016.07.013_bib26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.07.013_bib27","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1128\/AAC.01953-15","article-title":"Substitutions at NS3 residue 155, 156, or 168 of hepatitis C virus genotypes 2 to 6 induce complex patterns of protease inhibitor resistance","volume":"59","author":"Jensen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2016.07.013_bib28","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2016.07.013_bib29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1099\/0022-1317-75-7-1761","article-title":"Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V\/3a","volume":"75","author":"Sakamoto","year":"1994","journal-title":"J\u00a0Gen Virol"},{"key":"10.1053\/j.gastro.2016.07.013_bib30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","author":"Hepatitis","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2016.07.013_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2016.07.013_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature14899","article-title":"SEC14L2 enables pan-genotype HCV replication in cell culture","volume":"524","author":"Saeed","year":"2015","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2016.07.013_bib33","doi-asserted-by":"crossref","first-page":"e1000475","DOI":"10.1371\/journal.ppat.1000475","article-title":"Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations","volume":"5","author":"Pietschmann","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2016.07.013_bib34","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1128\/JVI.01362-07","article-title":"Cell culture adaptation of hepatitis C virus and in\u00a0vivo viability of an adapted variant","volume":"81","author":"Kaul","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2016.07.013_bib35","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JVI.02177-10","article-title":"A\u00a0comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes","volume":"85","author":"Schmitt","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2016.07.013_bib36","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1021\/jm401398x","article-title":"Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A","volume":"57","author":"DeGoey","year":"2014","journal-title":"J\u00a0Med Chem"},{"key":"10.1053\/j.gastro.2016.07.013_bib37","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1128\/AAC.01390-15","article-title":"Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir","volume":"59","author":"Liu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2016.07.013_bib38","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.02495-13","article-title":"Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C virus NS5B polymerase","volume":"58","author":"Lemm","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2016.07.013_bib39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/AAC.04619-14","article-title":"In\u00a0vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitor","volume":"59","author":"Kati","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2016.07.013_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","article-title":"Sofosbuvir inhibits hepatitis E virus replication in\u00a0vitro and results in an additive effect when combined with ribavirin","volume":"150","author":"Dao Thi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2016.07.013_bib41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/jvh.12405","article-title":"Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy","volume":"22","author":"Hedskog","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2016.07.013_bib42","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/AAC.02494-12","article-title":"Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir","volume":"57","author":"Wang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2016.07.013_bib43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/infdis\/jit562","article-title":"In\u00a0vivo emergence of a novel mutant L159F\/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir","volume":"209","author":"Tong","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2016.07.013_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/infdis\/jiv564","article-title":"L159F and V321A sofosbuvir-associated hepatitis C virus NS5B substitutions","volume":"213","author":"Svarovskaia","year":"2016","journal-title":"J\u00a0Infect Dis"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508516348090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508516348090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:42:44Z","timestamp":1762162964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508516348090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0016508516348090"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2016.07.013","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the AGA Institute","name":"copyright","label":"Copyright"}]}}